News

Healthcare

Start Cooking Today: Tips & Tech for Food Safety

Start Cooking Today: Tips & Tech for Food Safety

Maggie Kimberl | Equities.com |

Did you know there are apps to help you learn how to cook?


Cancer Vaccine Developer Expands Its Collaboration with Merck

The Life Sciences Report | Equities.com |

In a Sept. 11 research note, Mackie Research Capital analyst Andre Uddin reported that IMV Inc. (IMV:TSX; IMMVD:OTCQX) is again collaborating with Merck, this time evaluating its DPX-Survivac with ...


Coverage Initiated on 'Emerging Antibiotics Growth Story with Multiple Levers for Upside'

The Life Sciences Report | Equities.com |

In a Sept. 11 research note, analyst Ed Arce reported that H.C. Wainwright & Co. launched coverage on Melinta Therapeutics Inc. (MLNT:NASDAQ) with a Buy rating and a $14 per share price target. The...


Medical Use of Nitric Oxide Expands as Costs Come Down

The Life Sciences Report | Equities.com |

The Life Sciences Report: Dr. Earl, thanks for joining us today. Would you tell us about yourself?


U.S. Biotech Partner Obtains Marketing Authorization for ADHD Treatment in Taiwan

The Life Sciences Report | Equities.com |

DURECT Corp. announced that Orient Pharma Co., Ltd., its licensee for certain Asian and South Pacific countries, has informed DURECT that it has obtained marketing authorization from the Ministry o...


Canadian Biopharma to Outlicense Pain Drug to South Korean Firm

The Life Sciences Report | Equities.com |

In a Sept. 5 research note, analyst Douglas Loe with Echelon Wealth Partners reported that Antibe Therapeutics Inc. (ATE:TSX.V; ATBPG:OTCQX) signed a $14.3 million licensing agreement with a South ...


Oncology-Focused Biotech Receives Orphan Status for AML Drug

The Life Sciences Report | Equities.com |

In an Aug. 21, 2018, research note, Ram Selvaraju, an analyst with H.C. Wainwright & Co., reported the FDA gave orphan drug status to ASLAN Pharmaceuticals' (ASLN:NASDAQ) ASLAN003 as a treatment fo...


Investor Opportunity Arises from Biopharma's Share Price Weakness on Competitor News

The Life Sciences Report | Equities.com |

In an Aug. 23, 2018 research note, analyst Jason Kolbert with H.C. Wainwright & Co. indicated the recent weakness in Adamis Pharmaceuticals Corp. (ADMP:OTCBB) shares is an opportunity.


Neurosciences Company Reports Potential for Improved Safety Profile for Alzheimer's Treatment

The Life Sciences Report | Equities.com |

ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the d...


Drug Company Receives $5 Million Milestone Payment

The Life Sciences Report | Equities.com |

DURECT Corp. (DRRX:NASDAQ) announced that it has received a $5 million milestone payment from Indivior Plc (INDV:LON), triggered by Indivior's approval of the New Drug Application (NDA) for PERSERI...